At the core of Katz’s philosophy is the belief that regulatory compliance must remain patient-centered. Compliance is not just about meeting technical checklists; it’s about ensuring therapies are safe, accessible, and effective. This is especially crucial in high-need areas like oncology and rare diseases, where regulatory frameworks must balance speed with rigor. Katz’s counsel emphasizes both safety and accessibility, ensuring companies bring treatments to patients in ways that meet scientific, legal, and ethical standards.